相关实验视频

Updated: May 3, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

尖端重叠技术减少了TAVR中的心脏起器植入:系统性审查和元分析

Mohammad Hazique¹, Zubair Jafar², Sameer Lohana¹

¹Department of Internal Medicine, Nuvance Health/Vassar Brothers Medical Center, Poughkeepsie, New York.

The American journal of cardiology

|June 29, 2025

概括

跨导管大动脉置换 (TAVR) 的 cusp overlap view (COV) 技术显著减少了接受自扩张 (SEV) 的患者永久心脏起器植入 (PPI) 的需要. 这种先进的成像方法还缩短了住院时间,并改善了手术结果.

科学领域:

心血管医学心血管医学
干预心脏病学干预心脏病学
医疗成像医学成像

背景情况:

过导管大动脉置换 (TAVR) 是对症状性大动脉狭窄的主要治疗方法.
需要永久心脏起器植入 (PPI) 的导电障碍是一个显著的并发症,特别是在自扩张 (SEV) 方面.
顶端重叠视图 (COV) 成像技术旨在改善门部署,与传统的共平面视图 (CPV) 相比.

研究的目的:

系统地审查和元分析COV技术与CPV对TAVR结果的影响.
评估COV对永久起器植入率 (PPI) 和其他程序指标的影响.

主要方法:

一项对14项涉及5,266名TAVR患者的研究的系统审查和元分析.
使用DerSimonian-Laird随机效应模型与I2进行异质性分析的数据.
将COV和CPV技术之间的结果进行比较.

主要成果:

COV技术与明显较低的PPI率 (11.2%与17.7%相比; OR = 0.63; p <0.0001) 有关.
冠状病毒组的患者住院时间较短 (SMD = -0.56; p = 0.016) 和平均跨膜梯度较低 (SMD = -0.10; p = 0.049).
COV表明了较高的门位置,与非冠状动脉和左冠状动脉尖端的平均距离明显较低 (SMD = -0.21; p <0.001).

结论:

尖端重叠视图 (COV) 技术显著降低了PPI率,并改善了与SEVs在TAVR中的程序结果.
通过最大限度地减少导电干扰和住院,优化资源利用,COV提高了患者的治疗结果.
建议进行进一步的随机对照试验,以确认益处并标准化TAVR协议.

关键词:

在TAVRR中,我们可以看到.导电干扰导电干扰顶端重叠投影的投影.这是一个心脏起器.通过导管更换大动脉门.

更多相关视频

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

相关概念视频

Mitral Regurgitation III: Medical Management

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...